Publication Interim Advice on the use of Rifampicin for post-exposure prophylaxis (PEP), in light of recent information on nitrosamine impurities in rifampicin ILEP Technical Commission . 2020; Download PDF
Publication HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae.. Vedithi S, Malhotra S, Skwark M, et al. Computational and structural biotechnology journal. 2020; Download PDF
Publication Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme. Richardus J, Tiwari A, Barth-Jaeggi T, et al. The Lancet. Global health. 2020; Download PDF
Publication Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India. Lavania M, Darlong J, Singh I, et al. Journal of global antimicrobial resistance. 2020; Download PDF
Publication Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches. Portelli S, Myung Y, Furnham N, et al. Scientific reports. 2020; 10 (1) : 18120. Download PDF
Publication The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis Schoenmakers A, Mieras L, Budiawan T, et al. Informa UK Limited. Research and Reports in Tropical Medicine. 2020; Download PDF
Publication Leprosy treatment: Can we replace opinions with research? Scollard D. PLoS neglected tropical diseases. 2020; 14 (10) : e0008636. Download PDF
Publication Leprosy Post-Exposure Prophylaxis with Single-dose Rifampicin. Health economic aspects in India Tiwari A. Erasmus University. Department of Public Health. 2020; Download PDF
Publication Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy. Shui T, Shi C, Jing Z, et al. The American journal of tropical medicine and hygiene. 2020;
Publication Treatment of histoid leprosy: a lack of consensus. Bartos G, Sheuring R, Combs A, et al. International journal of dermatology. 2020;
Publication Profilaxis post-exposición para lepra con dosis única de rifampicina: manual para su implementación Barth-Jaeggi T, Cavaliero A, Aerts A, et al. Fontilles, Rev. Leprol.. 2020; 4 (32) : 263-272.
Publication Alternative Leprosy Treatment Using Rifampicin Ofloxacin Minocycline (ROM) Regimen – Two Case Reports Widjaja Y, Djawad K, Amin S, et al. Walter de Gruyter GmbH. Serbian Journal of Dermatology and Venereology. 2019; 11 (3) : 89-93. Download PDF
Publication Development of an Assay System for Genotyping Mycobacterium leprae Resistant to Dapsone, Rifampicin, and Ofloxacin Tanod V, Bela B, Menaldi S, et al. Indian journal of leprosy. 2019; 91 (3) : 185-195. Download PDF
Publication Successful treatment of rifampicin resistant case of leprosy by WHO recommended ofloxacin and minocycline regimen Lavania M, Darlong J, Reddy A, et al. Leprosy review. 2019; 90 (4) : 456–459. Download PDF
Publication Depicting the DNA binding and photo-nuclease ability of anti-mycobacterial drug rifampicin: A biophysical and molecular docking perspective. Chakraborty A, Panda AK, Ghosh R, et al. International journal of biological macromolecules. 2019;
Publication Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach. Cruz R, Bührer-Sékula S, Penna G, et al. Anais brasileiros de dermatologia. 2018; 93 (3) : 377-384. Download PDF
Publication Rifampicin can induce antibiotic tolerance in mycobacteria via paradoxical changes in rpoB transcription. Zhu J, Wang B, Pan M, et al. Nature communications. 2018; 9 (1) : 4218. Download PDF
Publication Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 200-9-15. Cambau, Saunderson, Matsuoka, Cole et al. Lockwood DN, Walker S. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2018;
Publication Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia. Tiwari A, Dandel S, Djupuri R, et al. BMC infectious diseases. 2018; 18 (1) : 324. Download PDF
Publication Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-2015. Cambau E, Saunderson P, Matsuoka M, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2018; Download PDF
